Cargando…
Napabucasin, a novel STAT3 inhibitor suppresses proliferation, invasion and stemness of glioblastoma cells
BACKGROUND: Glioblastoma (GBM) cells with stem cell-like properties are called glioma stem cells (GSCs). GSCs display highly treatment resistance and are responsible for tumor recurrence. Napabucasin (BBI608), a novel small molecule inhibitor of STAT3, has been identified to eliminate stemness-like...
Autores principales: | Han, Dongfeng, Yu, Tianfu, Dong, Nan, Wang, Bo, Sun, Fei, Jiang, Dehua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612138/ https://www.ncbi.nlm.nih.gov/pubmed/31277685 http://dx.doi.org/10.1186/s13046-019-1289-6 |
Ejemplares similares
-
Suppression of prostate cancer progression by cancer cell stemness inhibitor napabucasin
por: Zhang, Yiming, et al.
Publicado: (2016) -
STAT3 inhibitor Napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing mice
por: Bitsch, Rebekka, et al.
Publicado: (2022) -
Napabucasin Induces Mouse Bone Loss by Impairing Bone Formation via STAT3
por: Huang, Xiangru, et al.
Publicado: (2021) -
Napabucasin Reduces Cancer Stem Cell Characteristics in Hepatocellular Carcinoma
por: Li, Ya, et al.
Publicado: (2020) -
Phase 1 study of napabucasin, a cancer stemness inhibitor, in patients with advanced solid tumors
por: Kawazoe, Akihito, et al.
Publicado: (2020)